Article info
Editorial
Clinical trials of biosimilars should become more similar
- Correspondence to Professor Jonathan Kay, Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Memorial Campus, 119 Belmont Street, Worcester, MA 01605, USA; jonathan.kay{at}umassmemorial.org
Citation
Clinical trials of biosimilars should become more similar
Publication history
- Received June 27, 2016
- Revised July 18, 2016
- Accepted July 31, 2016
- First published August 25, 2016.
Online issue publication
December 09, 2016
Article Versions
- Previous version (25 August 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/